Clinical Trials Browser

OTHER × Insulin-Like Growth Factor I, Resistance To × Clear all

NCT06866548 2025-12-04

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Insulin-Like Growth Factor I, Resistance To, Neoplasm Metastasis, Prostatic Neoplasms

NCT04767750 2022-04-07

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Diabetes Mellitus, Type 2, Carcinoma, Hepatocellular, Neoplasms

NCT00799240 2014-11-07

IMPACT

Phase 2 Completed

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion